Stay updated on PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added revision v3.4.3 and removed revision v3.4.2 in the record history.
    Difference
    0.1%
    Check dated 2026-03-12T21:27:13.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    A minor update to the record history shows a new revision v3.4.2 added and v3.4.1 removed, with no substantive study content affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:10:49.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The Record History shows a new revision (v3.4.1) added and the previous revision (v3.4.0) removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T22:49:04.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The new version adds a glossary toggle and color-coded change highlights (green for additions, red for deletions) with an updated revision notice (v3.4.0). The old revision note (v3.3.4) and the 'No FEAR Act Data' text were removed.
    Difference
    1%
    Check dated 2026-01-28T21:40:13.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new revision entry is added to the Record History: Revision: v3.3.4. This is a routine site revision update and does not modify trial data or study details.
    Difference
    0.1%
    Check dated 2026-01-14T04:12:01.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Record History now lists the latest known status and sponsor (Jiangsu HengRui Medicine Co., Ltd.) with a 2022-10 date, and includes Recruitment Status and Study Status details as of 2022-11-16.
    Difference
    0.9%
    Check dated 2026-01-07T02:06:17.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.